Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Regis Healthcare Ltd. (REG) vs. Competitors

27 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:REGRegis Healthcare Ltd.AUD 4.80AUD 1.54B27.63-35.57%Moderate BuyUnlock the AU:REG analyst price target with TipRanks PremiumAU:REGUnlock the AU:REG top-analyst price target with TipRanks Premium
AU:EPNEpsilon Healthcare LimitedAUD 0.02AUD 9.34M80.000.00%―Unlock the AU:EPN analyst price target with TipRanks PremiumAU:REG vs AU:EPNUnlock the AU:EPN top-analyst price target with TipRanks Premium
AU:HLSHealius LimitedAUD 0.60AUD 421.18M-1.01-33.70%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:REG vs AU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:RHCRamsay Health CareAUD 53.65AUD 12.62B40.4070.53%HoldUnlock the AU:RHC analyst price target with TipRanks PremiumAU:REG vs AU:RHCUnlock the AU:RHC top-analyst price target with TipRanks Premium
AU:AHCAustco Healthcare LimitedAUD 0.26AUD 97.44M10.74-40.23%Moderate BuyUnlock the AU:AHC analyst price target with TipRanks PremiumAU:REG vs AU:AHCUnlock the AU:AHC top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 20.07AUD 9.87B16.24-4.47%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:REG vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:REGRegis Healthcare Ltd.4.80-2.51-34.34%
AU:EPNEpsilon Healthcare Limited0.020.000.00%
AU:HLSHealius Limited0.60-0.28-31.82%
AU:RHCRamsay Health Care53.6522.9874.96%
AU:AHCAustco Healthcare Limited0.26-0.16-38.10%
AU:SHLSonic Healthcare Limited20.070.231.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts